Pharmacokinetics and tolerance of nicotinamide combined with radiation therapy in patients with glioblastoma multiforms

被引:0
|
作者
Cartei, F.
Danesi, R.
Ducci, F.
Fatigante, L.
Caciagli, P.G.
Del Tacca, M.
Luddaga, M.
机构
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] RADIATION-THERAPY IN TREATMENT OF GLIOBLASTOMA
    ONOYAMA, Y
    ABE, M
    YABUMOTO, E
    SAKAMOTO, T
    NISHIDAI, T
    SUYAMA, S
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1976, 126 (03) : 481 - 492
  • [42] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Ney, Douglas E.
    Carlson, Julie A.
    Damek, Denise M.
    Gaspar, Laurie E.
    Kavanagh, Brian D.
    Kleinschmidt-DeMasters, B. K.
    Waziri, Allen E.
    Lillehei, Kevin O.
    Reddy, Krishna
    Chen, Changhu
    JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (01) : 135 - 143
  • [43] Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma
    Douglas E. Ney
    Julie A. Carlson
    Denise M. Damek
    Laurie E. Gaspar
    Brian D. Kavanagh
    B. K. Kleinschmidt-DeMasters
    Allen E. Waziri
    Kevin O. Lillehei
    Krishna Reddy
    Changhu Chen
    Journal of Neuro-Oncology, 2015, 122 : 135 - 143
  • [44] GLIOBLASTOMA FOLLOWING RADIATION-THERAPY
    HOLNESS, RO
    SANGALANG, VE
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1979, 6 (03) : 388 - 388
  • [45] Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme
    Aherne, Noel J.
    Benjamin, Linus C.
    Horsley, Patrick J.
    Silva, Thomaz
    Wilcox, Shea
    Amalaseelan, Julan
    Dwyer, Patrick
    Tahir, Abdul M. R.
    Hill, Jacques
    Last, Andrew
    Hansen, Carmen
    McLachlan, Craig S.
    Lee, Yvonne L.
    Mckay, Michael J.
    Shakespeare, Thomas P.
    NEUROLOGY RESEARCH INTERNATIONAL, 2014, 2014
  • [46] Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma
    Wang, Tony J. C.
    Wu, Cheng-Chia
    Jani, Ashish
    Estrada, Juan
    Ung, Timothy
    Chow, Daniel S.
    Soun, Jennifer E.
    Saad, Shumaila
    Qureshi, Yasir H.
    Gartrell, Robyn
    Saadatmand, Heva J.
    Saraf, Anurag
    Garrett, Matthew D.
    Grubb, Christopher
    Isaacson, Steven R.
    Cheng, Simon K.
    Sisti, Michael B.
    Bruce, Jeffrey N.
    Sheth, Sameer A.
    Lassman, Andrew B.
    Iwamoto, Fabio M.
    McKhann, Guy M., II
    PRACTICAL RADIATION ONCOLOGY, 2016, 6 (05) : 306 - 314
  • [47] Optune (Tumor Therapy Area) in the clinical Routine for the Treatment of Glioblastoma Patients in Radiation Therapy in Stendal
    Weinstrauch, E.
    Lohm, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S62 - S62
  • [48] TREATMENT OUTCOMES OF STEREOTACTIC RADIOTHERAPY COMBINED WITH BEVACIZUMAB THERAPY IN RECURRENT GLIOBLASTOMA PATIENTS
    Sonoda, Yukihiko
    Matsuda, Ken-ichiro
    NEURO-ONCOLOGY, 2018, 20 : 24 - 24
  • [49] Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma
    Grossman, Stuart A.
    Olson, Jeffrey
    Batchelor, Tracy
    Peereboom, David
    Lesser, Glenn
    Desideri, Serena
    Ye, Xiaobu
    Hammour, Tarek
    Supko, Jeffrey G.
    NEURO-ONCOLOGY, 2008, 10 (02) : 190 - 198
  • [50] Hypofractionated Versus Standard Radiation Therapy With or Without Temozolomide for Older Glioblastoma Patients
    Fiorica, Francesco
    Colella, Maria
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (04): : 939 - 939